Utopia Biocon Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 76.16%
- Profit Growth -15568.61%
- Ebitda 46.44%
- Net Worth -1439.59%
- Total Assets -0.62%
About Utopia Biocon
Utopia Biocon Private Limited (UBPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 September 2018 (Six years and four months 29 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Prodyot Bandyopadhyay, Bandana Bandyopadhyay, and Sanjib Pratihar serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U72100WB2018PTC227627
- Company No.
227627
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Utopia Biocon?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prodyot Bandyopadhyay  | Director | 04-Sep-2018 | Current |
| Bandana Bandyopadhyay | Director | 08-Oct-2018 | Current |
| Sanjib Pratihar | Director | 17-Jan-2022 | Current |
Financial Performance of Utopia Biocon.
Utopia Biocon Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 76.16% increase. The company also saw a substantial fall in profitability, with a 15568.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1439.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Utopia Biocon?
Unlock access to Utopia Biocon's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Utoptech Consultancy Private LimitedProdyot Bandyopadhyay and Bandana Bandyopadhyay are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Utopia Biocon?
Unlock and access historical data on people associated with Utopia Biocon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Utopia Biocon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Utopia Biocon's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
